Venous thromboembolism: current management

被引：6
作者：
Stevens, Hannah [1 ,6 ]
Huyen Tran [2 ,3 ,6 ]
Gibbs, Harry [4 ,5 ]
机构：
[1] Alfred Hlth, Dept Haematol, Melbourne, Vic, Australia
[2] Alfred Hlth, Dept Haematol, Haemostasis & Thrombosis Unit, Melbourne, Vic, Australia
[3] Alfred Hlth, Haemophilia Treatment Ctr, Melbourne, Vic, Australia
[4] Alfred Hlth, Outpatients Program, Melbourne, Vic, Australia
[5] Alfred Hlth, Dept Gen Med, Gen Med, Melbourne, Vic, Australia
[6] Monash Univ, Melbourne, Vic, Australia
来源：
AUSTRALIAN PRESCRIBER | 2019年 / 42卷 / 04期
关键词：
anticoagulants; apixaban; rivaroxaban; venous thromboembolism; warfarin; DIRECT ORAL ANTICOAGULANTS; DEEP-VEIN THROMBOSIS; ANTITHROMBOTIC THERAPY; PULMONARY-EMBOLISM; EXTENDED TREATMENT; RIVAROXABAN; PREVENTION; RECURRENCE; APIXABAN; GUIDANCE;
D O I：
10.18773/austprescr.2019.039
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Anticoagulation is indicated in most cases of venous thromboembolism. Monotherapy with rivaroxaban or apixaban is the preferred option for most adults with acute venous thromboembolism. There are no recommended dose reductions for rivaroxaban or apixaban in venous thromboembolism, unlike for atrial fibrillation. The initial duration of anticoagulation is usually three months. Extended treatment with low-dose rivaroxaban or apixaban is effective in preventing recurrence in patients with a continuing increased risk of thromboembolism. Both drugs have low rates of major bleeding.
引用
收藏
页码：123 / 126
页数：4
相关论文
共 30 条
[1]   Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review [J].
Adcock, D. M. ;
Gosselin, R. .
THROMBOSIS RESEARCH, 2015, 136 (01) :7-12
[2]   Oral Apixaban for the Treatment of Acute Venous Thromboembolism [J].
Agnelli, Giancarlo ;
Buller, Harry R. ;
Cohen, Alexander ;
Curto, Madelyn ;
Gallus, Alexander S. ;
Johnson, Margot ;
Masiukiewicz, Urszula ;
Pak, Raphael ;
Thompson, John ;
Raskob, Gary E. ;
Weitz, Jeffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :799-808
[3]   Apixaban for Extended Treatment of Venous Thromboembolism [J].
Agnelli, Giancarlo ;
Buller, Harry R. ;
Cohen, Alexander ;
Curto, Madelyn ;
Gallus, Alexander S. ;
Johnson, Margot ;
Porcari, Anthony ;
Raskob, Gary E. ;
Weitz, Jeffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08) :699-708
[4]   Current Concepts: Acute Pulmonary Embolism. [J].
Agnelli, Giancarlo ;
Becattini, Cecilia .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :266-274
[5]  
BARRITT DW, 1960, LANCET, V1, P1309
[6]   Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [J].
Bauersachs, Rupert ;
Berkowitz, Scott D. ;
Brenner, Benjamin ;
Buller, Harry R. ;
Decousus, Herve ;
Gallus, Alex S. ;
Lensing, Anthonie W. ;
Misselwitz, Frank ;
Prins, Martin H. ;
Raskob, Gary E. ;
Segers, Annelise ;
Verhamme, Peter ;
Wells, Phil ;
Agnelli, Giancarlo ;
Bounameaux, Henri ;
Cohen, Alexander ;
Davidson, Bruce L. ;
Piovella, Franco ;
Schellong, Sebastian .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2499-2510
[7]   Aspirin for Preventing the Recurrence of Venous Thromboembolism [J].
Becattini, Cecilia ;
Agnelli, Giancarlo ;
Schenone, Alessandro ;
Eichinger, Sabine ;
Bucherini, Eugenio ;
Silingardi, Mauro ;
Bianchi, Marina ;
Moia, Marco ;
Ageno, Walter ;
Vandelli, Maria Rita ;
Grandone, Elvira ;
Prandoni, Paolo .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21) :1959-1967
[8]   Increasing Understanding Regarding the Risk of Concomitant Use of Carbamazepine and Direct Oral Anticoagulants [J].
Bortz, Hadley ;
Corallo, Carmela E. ;
Huyen Tran .
JOURNAL OF PHARMACY PRACTICE, 2019, 32 (02) :123-125
[9]   Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism [J].
Buller, Harry R. ;
Prins, Martin H. ;
Lensing, Anthonie W. A. ;
Decousus, Herve ;
Jacobson, Barry F. ;
Minar, Erich ;
Chlumsky, Jaromir ;
Verhamme, Peter ;
Wells, Phil ;
Agnelli, Giancarlo ;
Cohen, Alexander ;
Berkowitz, Scott D. ;
Bounameaux, Henri ;
Davidson, Bruce L. ;
Misselwitz, Frank ;
Gallus, Alex S. ;
Raskob, Gary E. ;
Schellong, Sebastian ;
Segers, Annelise .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14) :1287-1297
[10]  
Cardiovascular Expert Group, 2018, ETG COMPL
123